Lineagen Completes Series A Funding Round At $10.8 Million
Lineagen Inc., Salt Lake City, Utah-based developer of genomic tests and services, secured another $5 million in venture funding. This completes its Series A round at $10.8 million. PrairieGold Venture Partners joined Lineagen’s other institutional investors.
30 August 2010•3 mins read
